You just read:

Viking Therapeutics Completes Safety, Tolerability and Pharmacokinetic Study of VK5211, a Selective Androgen Receptor Modulator (SARM), in Healthy Elderly Subjects

News provided by

Viking Therapeutics, Inc

Oct 20, 2015, 07:30 ET